Shares of Transenterix Inc (NASDAQ:TRXC) fell 11.3% during mid-day trading on Thursday . The stock traded as low as $3.35 and last traded at $3.27. 16,779,476 shares changed hands during mid-day trading, an increase of 214% from the average session volume of 5,336,480 shares. The stock had previously closed at $3.69.
Separately, Zacks Investment Research raised Transenterix from a “hold” rating to a “buy” rating and set a $0.75 price target on the stock in a research note on Thursday, July 13th.
The stock’s 50 day moving average is $1.49 and its 200-day moving average is $0.92. The stock’s market cap is $457.49 million.
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Sabby Management LLC acquired a new stake in shares of Transenterix in the 2nd quarter worth about $2,456,000. Royal Bank of Canada raised its holdings in shares of Transenterix by 17.1% in the 2nd quarter. Royal Bank of Canada now owns 418,867 shares of the company’s stock worth $298,000 after acquiring an additional 61,034 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of Transenterix by 7,137.7% in the 2nd quarter. Goldman Sachs Group Inc. now owns 1,203,199 shares of the company’s stock worth $854,000 after acquiring an additional 1,186,575 shares during the last quarter. UBS Oconnor LLC acquired a new stake in shares of Transenterix in the 2nd quarter worth about $390,000. Finally, LMR Partners LLP acquired a new stake in shares of Transenterix in the 2nd quarter worth about $189,000.
ILLEGAL ACTIVITY WARNING: This news story was first reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this news story on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be accessed at https://www.chaffeybreeze.com/2017/10/19/transenterix-inc-trxc-stock-price-down-11-3.html.
Transenterix Company Profile
TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.
Receive News & Ratings for Transenterix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix Inc and related companies with MarketBeat.com's FREE daily email newsletter.